Catalyst Wire Dossier Catalyst Wire Dossier

Pramipexole dihydrochloride extended-release

pramipexole dihydrochloride · Vitruvias Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Pramipexole dihydrochloride extended-release, covering 2021-06-11 to 2025-02-19. Get the full timeline:

Most recent: FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Vitruvias Therapeutics, Inc.)

See pricing